Thema: US94352A1043
WVE, US94352A1043
trader-5129770_1920.jpg - Foto: THN
Wave Life Sciences stock enters key week after Q3 update
Investors in Wave Life Sciences stock have a fresh pipeline catalyst ahead. The company will present new platform data at a virtual Research Day on November 4.
ad-hoc-news.de, heute 13:55 Uhr
WVE, US94352A1043
Wave Life Sciences stock trades at EUR 3.27: Q3 revenue ...
The November 4, 2026 Research Day adds a dated catalyst for Wave Life Sciences stock, while cash totaled USD 431 million at quarter-end.
ad-hoc-news.de, 29.10.26 14:24 Uhr
WVE, US94352A1043
Wave reports third-quarter results while Wave Life Sciences ...
Q3 revenue rose to USD 13.2 million from USD 7.6 million. Wave Life Sciences stock trades at EUR 3.08 on October 27, 2026.
ad-hoc-news.de, 27.10.26 14:04 Uhr
WVE, US94352A1043
Wave Life Sciences schedules October 27 results for Wave ...
Second-quarter revenue reached USD 2.27 million versus USD 7.45 million expected. October 27 is the next date for Wave Life Sciences stock.
ad-hoc-news.de, 25.10.26 13:54 Uhr
WVE, US94352A1043
Wave sets Research Day for November 4: Wave Life Sciences ...
Wave Life Sciences stock costs EUR 2.85 on October 20, 2026. Revenue for the second quarter was USD 2.27 million versus USD 7.45 million expected.
ad-hoc-news.de, 20.10.26 14:23 Uhr
WVE, US94352A1043
UBS upgrades Wave Life Sciences stock as October 20 panel ...
UBS upgraded Wave Life Sciences stock to Strong Buy on October 17, 2026. Wave presents at 9:45 a.m. ET on October 20, 2026.
ad-hoc-news.de, 18.10.26 13:19 Uhr
WVE, US94352A1043
UBS starts coverage of Wave Life Sciences stock with USD ...
Wave Life Sciences stock costs EUR 2.77 on October 15, 2026. Q2 2026 revenue was USD 2.27 million versus USD 7.45 million expected.
ad-hoc-news.de, 15.10.26 13:01 Uhr
WVE, US94352A1043
Wave Life Sciences aligns with FDA. Wave Life Sciences stock ...
FDA supports a two-year trial with a one-year interim review. Wave Life Sciences stock costs EUR 3.39 on October 6, 2026 after EUR 3.32.
ad-hoc-news.de, 06.10.26 15:03 Uhr
WVE, US94352A1043
Wave Life Sciences stock fell 2.58 percent as FDA path advances ...
